Advertisement
Screener

ORAGENICS, INC. (OGEN) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

ORAGENICS, INC. Operating Expenses

ORAGENICS, INC. (OGEN) reported Operating Expenses of $2.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-13

  • ORAGENICS, INC. operating expenses for the quarter ending 2026-06-30 was $2.59M, a 51.24% increase year-over-year.
  • ORAGENICS, INC. operating expenses for the quarter ending 2026-03-31 was $2.26M, a 11.34% increase year-over-year.
  • ORAGENICS, INC. operating expenses for the quarter ending 2025-12-31 was $2.50M, a 25.54% decline year-over-year.
  • ORAGENICS, INC. operating expenses for the quarter ending 2025-09-30 was $3.12M, a 28.17% increase year-over-year.
  • ORAGENICS, INC. operating expenses for fiscal 2025 was $9.36M, a 11.33% decline from fiscal 2024.
  • ORAGENICS, INC. operating expenses for fiscal 2024 was $10.56M, a 49.58% decline from fiscal 2023.
  • ORAGENICS, INC. operating expenses for fiscal 2023 was $20.94M, a 43.91% increase from fiscal 2022.
  • ORAGENICS, INC. operating expenses for fiscal 2022 was $14.55M, a 8.23% decline from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 4 monthOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-06-30$2.59M
10-Q · filed 2026-08-13
$4.85M
10-Q · filed 2026-08-13
$7.35M
derived: sum of 3 quarters · filed 2026-08-13
$10.47M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$2.26M
10-Q · filed 2026-05-08
$4.75M
derived: sum of 2 quarters · filed 2026-05-08
$7.88M
derived: sum of 3 quarters · filed 2026-05-08
$9.59M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$5.62M
derived: sum of 2 quarters · filed 2026-03-16
$7.34M
derived: sum of 3 quarters · filed 2026-08-13
$9.36M
10-K · filed 2026-03-16
2025-09-30$3.12M
10-Q · filed 2025-11-07
$4.84M
derived: sum of 2 quarters · filed 2026-08-13
$6.86M
10-Q · filed 2025-11-07
$10.22M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$1.71M
10-Q · filed 2026-08-13
$3.74M
10-Q · filed 2026-08-13
$7.10M
derived: sum of 3 quarters · filed 2026-08-13
$9.53M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$2.03M
10-Q · filed 2026-05-08
$5.38M
derived: sum of 2 quarters · filed 2026-05-08
$7.82M
derived: sum of 3 quarters · filed 2026-05-08
$10.12M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$3.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$5.79M
derived: sum of 2 quarters · filed 2026-03-16
$8.10M
derived: sum of 3 quarters · filed 2026-03-16
$10.56M
10-K · filed 2026-03-16
2024-09-30$2.44M
10-Q · filed 2025-11-07
$4.74M
derived: sum of 2 quarters · filed 2025-11-07
$7.20M
10-Q · filed 2025-11-07
$20.00M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$2.31M
10-Q · filed 2025-08-08
$4.77M
10-Q · filed 2025-08-08
$17.56M
derived: sum of 3 quarters · filed 2025-08-08
$19.66M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$2.46M
10-Q · filed 2025-05-09
$15.26M
derived: sum of 2 quarters · filed 2025-05-09
$17.36M
derived: sum of 3 quarters · filed 2025-05-09
$20.48M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$12.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
$14.90M
derived: sum of 2 quarters · filed 2025-03-14
$18.02M
derived: sum of 3 quarters · filed 2025-03-14
$20.94M
10-K · filed 2025-03-14
2023-09-30$2.10M
10-Q · filed 2024-11-13
$5.22M
derived: sum of 2 quarters · filed 2024-11-13
$8.15M
10-Q · filed 2024-11-13
$10.45M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$3.12M
10-Q · filed 2024-08-09
$6.04M
10-Q · filed 2024-08-09
$8.34M
derived: sum of 3 quarters · filed 2024-08-09
$12.34M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$2.92M
10-Q · filed 2024-05-15
$5.22M
derived: sum of 2 quarters · filed 2024-05-15
$9.21M
derived: sum of 3 quarters · filed 2024-05-15
$12.85M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$6.29M
derived: sum of 2 quarters · filed 2024-03-29
$9.93M
derived: sum of 3 quarters · filed 2024-03-29
$14.55M
10-K · filed 2024-03-29
$14.55M
10-K · filed 2023-04-17
2022-09-30$3.99M
10-Q · filed 2023-11-09
$4.04M
10-Q · filed 2022-11-14
$7.63M
derived: sum of 2 quarters · filed 2023-11-09
$12.25M
10-Q · filed 2023-11-09
$14.19M
10-Q · filed 2022-11-14
$14.64M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$3.63M
10-Q · filed 2023-08-11
$4.08M
10-Q · filed 2022-08-09
$3.63M
10-Q/A · filed 2023-04-14
$8.26M
10-Q · filed 2023-08-11
$10.15M
10-Q · filed 2022-08-09
$10.65M
derived: sum of 3 quarters · filed 2023-08-11
$15.04M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$4.63M
10-Q · filed 2023-05-12
$6.07M
10-Q · filed 2022-05-13
$7.01M
derived: sum of 2 quarters · filed 2023-05-12
$11.41M
derived: sum of 3 quarters · filed 2023-05-12
$15.25M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$2.39M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17
$6.78M
derived: sum of 2 quarters · filed 2023-04-17
$10.62M
derived: sum of 3 quarters · filed 2023-04-17
$15.86M
10-K · filed 2023-04-17
2021-09-30$4.39M
10-Q/A · filed 2023-04-14
$8.23M
derived: sum of 2 quarters · filed 2023-04-14
$13.47M
10-Q/A · filed 2023-04-14
$8.92M
derived: sum of 4 quarters · filed 2023-04-14
2021-06-30$3.84M
10-Q/A · filed 2023-04-14
$9.08M
10-Q/A · filed 2023-04-14
$4.53M
derived: sum of 3 quarters · filed 2023-04-14
$9.03M
derived: sum of 4 quarters · filed 2023-04-14
2021-03-31$5.24M
10-Q/A · filed 2023-04-14
$688.46K
derived: sum of 2 quarters · filed 2023-04-14
$5.20M
derived: sum of 3 quarters · filed 2023-04-14
$17.55M
derived: sum of 4 quarters · filed 2023-04-14
2020-12-31-$4.55M
10-K · filed 2021-03-01
-$40.65K
derived: sum of 2 quarters · filed 2021-11-15
$12.31M
derived: sum of 3 quarters · filed 2021-11-15
$26.64M
10-K/A · filed 2022-07-29
2020-09-30$4.51M
10-Q · filed 2021-11-15
$16.86M
derived: sum of 2 quarters · filed 2021-11-15
$22.09M
10-Q · filed 2021-11-15
$25.75M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$12.35M
10-Q · filed 2021-08-16
$17.58M
10-Q · filed 2021-08-16
$21.24M
derived: sum of 3 quarters · filed 2021-08-16
$25.16M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$5.23M
10-Q · filed 2021-05-03
$8.89M
derived: sum of 2 quarters · filed 2021-05-03
$12.81M
derived: sum of 3 quarters · filed 2021-05-03
$17.72M
derived: sum of 4 quarters · filed 2021-05-03
2019-12-31$3.66M
10-K · filed 2021-03-01
$7.58M
derived: sum of 2 quarters · filed 2021-03-01
$12.48M
derived: sum of 3 quarters · filed 2021-03-01
$15.88M
10-K · filed 2021-03-01
2019-09-30$3.92M
10-K · filed 2021-03-01
$8.83M
derived: sum of 2 quarters · filed 2021-03-01
$12.22M
10-Q · filed 2020-11-10
$15.04M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$4.90M
10-K · filed 2021-03-01
$8.30M
10-Q · filed 2020-08-14
$11.12M
derived: sum of 3 quarters · filed 2021-03-01
$13.89M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$3.39M
10-K · filed 2021-03-01
$6.22M
derived: sum of 2 quarters · filed 2021-03-01
$8.98M
derived: sum of 3 quarters · filed 2021-03-01
$11.27M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$2.82M
10-K · filed 2020-03-04
$5.59M
derived: sum of 2 quarters · filed 2020-03-04
$7.87M
derived: sum of 3 quarters · filed 2020-03-04
$9.99M
10-K · filed 2020-03-04
2018-09-30$2.76M
10-K · filed 2020-03-04
$5.05M
derived: sum of 2 quarters · filed 2020-03-04
$7.17M
10-Q · filed 2019-11-14
$8.58M
derived: sum of 4 quarters · filed 2020-03-04
2018-06-30$2.28M
10-Q · filed 2018-08-13
$4.41M
10-Q · filed 2019-08-14
$5.82M
derived: sum of 3 quarters · filed 2020-03-04
$7.74M
derived: sum of 4 quarters · filed 2020-03-04
2018-03-31$2.12M
10-K · filed 2020-03-04
$3.53M
derived: sum of 2 quarters · filed 2020-03-04
$5.46M
derived: sum of 3 quarters · filed 2020-03-04
$6.85M
derived: sum of 4 quarters · filed 2020-03-04
2017-12-31$1.41M
10-K · filed 2019-03-29
$3.33M
derived: sum of 2 quarters · filed 2019-03-29
$4.73M
derived: sum of 3 quarters · filed 2019-03-29
$6.72M
10-K · filed 2019-03-29
2017-09-30$1.92M
10-K · filed 2019-03-29
$3.32M
derived: sum of 2 quarters · filed 2019-03-29
$5.31M
10-Q · filed 2018-11-13
$8.01M
derived: sum of 4 quarters · filed 2019-03-29
2017-06-30$1.40M
10-K · filed 2019-03-29
$3.38M
10-Q · filed 2018-08-13
$6.09M
derived: sum of 3 quarters · filed 2019-03-29
$8.12M
derived: sum of 4 quarters · filed 2019-03-29
2017-03-31$1.99M
10-K · filed 2019-03-29
$4.70M
derived: sum of 2 quarters · filed 2019-03-29
$6.72M
derived: sum of 3 quarters · filed 2019-03-29
$8.46M
derived: sum of 4 quarters · filed 2019-03-29
2016-12-31$2.71M
10-K · filed 2018-02-16
$4.73M
derived: sum of 2 quarters · filed 2018-02-16
$6.47M
derived: sum of 3 quarters · filed 2018-02-16
$8.54M
10-K · filed 2018-02-16
2016-09-30$2.03M
10-K · filed 2018-02-16
$3.76M
derived: sum of 2 quarters · filed 2018-02-16
$5.83M
10-Q · filed 2017-10-31
$8.03M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30$1.73M
10-K · filed 2018-02-16
$3.81M
10-Q · filed 2017-08-14
$6.00M
derived: sum of 3 quarters · filed 2018-02-16
$7.87M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31$2.07M
10-K · filed 2018-02-16
$2.24M
10-Q · filed 2016-05-16
$4.27M
derived: sum of 2 quarters · filed 2018-02-16
$6.14M
derived: sum of 3 quarters · filed 2018-02-16
$12.62M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31$2.20M
10-K · filed 2017-02-27
$2.34M
10-K · filed 2016-03-30
$4.06M
derived: sum of 2 quarters · filed 2017-02-27
$10.55M
derived: sum of 3 quarters · filed 2017-02-27
$11.78M
10-K · filed 2017-02-27
$12.35M
10-K · filed 2016-03-30
2015-09-30$1.87M
10-K · filed 2017-02-27
$2.02M
10-Q · filed 2015-11-06
$8.35M
derived: sum of 2 quarters · filed 2017-02-27
$9.59M
10-Q · filed 2016-11-14
$10.00M
10-Q · filed 2015-11-06
$11.09M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30$6.34M
10-K · filed 2017-02-27
$6.49M
10-K · filed 2016-03-30
$7.72M
10-Q · filed 2016-08-15
$7.98M
10-Q · filed 2015-08-07
$9.22M
derived: sum of 3 quarters · filed 2017-02-27
$10.38M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$1.37M
10-K · filed 2017-02-27
$1.49M
10-Q · filed 2015-05-08
$2.74M
derived: sum of 2 quarters · filed 2017-02-27
$3.90M
derived: sum of 3 quarters · filed 2017-02-27
$5.98M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$1.36M
10-K · filed 2016-03-30
$2.52M
derived: sum of 2 quarters · filed 2016-03-30
$4.60M
derived: sum of 3 quarters · filed 2016-03-30
$6.39M
10-K · filed 2016-03-30
2014-09-30$1.16M
10-K · filed 2016-03-30
$3.24M
derived: sum of 2 quarters · filed 2016-03-30
$5.03M
10-Q · filed 2015-11-06
$8.46M
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30$2.08M
10-K · filed 2016-03-30
$3.86M
10-Q · filed 2015-08-07
$7.29M
derived: sum of 3 quarters · filed 2016-03-30
$16.76M
derived: sum of 4 quarters · filed 2016-03-30
2014-03-31$1.78M
10-K · filed 2016-03-30
$5.21M
derived: sum of 2 quarters · filed 2016-03-30
$14.68M
derived: sum of 3 quarters · filed 2016-03-30
$16.83M
derived: sum of 4 quarters · filed 2016-03-30
2013-12-31$3.43M
10-K · filed 2015-02-27
$12.89M
derived: sum of 2 quarters · filed 2015-02-27
$15.05M
derived: sum of 3 quarters · filed 2015-02-27
$16.90M
10-K · filed 2015-02-27
2013-09-30$9.47M
10-K · filed 2015-02-27
$11.62M
derived: sum of 2 quarters · filed 2015-02-27
$13.47M
10-Q · filed 2014-11-03
$15.49M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$2.16M
10-K · filed 2015-02-27
$4.00M
10-Q · filed 2014-08-07
$6.02M
derived: sum of 3 quarters · filed 2015-02-27
$8.22M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$1.85M
10-K · filed 2015-02-27
$3.86M
derived: sum of 2 quarters · filed 2015-02-27
$6.06M
derived: sum of 3 quarters · filed 2015-02-27
$13.07M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$2.01M
10-K · filed 2014-02-28
$4.21M
derived: sum of 2 quarters · filed 2014-02-28
$11.22M
derived: sum of 3 quarters · filed 2014-02-28
$12.89M
10-K · filed 2014-02-28
2012-09-30$2.20M
10-K · filed 2014-02-28
$9.21M
derived: sum of 2 quarters · filed 2014-02-28
$10.87M
10-Q · filed 2013-10-25
$12.93M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30$7.01M
10-K · filed 2014-02-28
$8.67M
10-Q · filed 2013-08-12
$10.73M
derived: sum of 3 quarters · filed 2014-02-28
$12.66M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31$1.66M
10-K · filed 2014-02-28
$3.72M
derived: sum of 2 quarters · filed 2014-02-28
$5.64M
derived: sum of 3 quarters · filed 2014-02-28
$7.97M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$2.06M
10-K · filed 2013-03-26
$3.98M
derived: sum of 2 quarters · filed 2013-03-26
$6.31M
derived: sum of 3 quarters · filed 2013-03-26
$8.08M
10-K · filed 2013-03-26
2011-09-30$1.93M
10-K · filed 2013-03-26
$4.25M
derived: sum of 2 quarters · filed 2013-03-26
$6.02M
10-Q · filed 2012-11-14
$8.15M
derived: sum of 4 quarters · filed 2013-03-26
2011-06-30$2.32M
10-K · filed 2013-03-26
$4.09M
10-Q · filed 2012-08-10
$6.23M
derived: sum of 3 quarters · filed 2013-03-26
$8.32M
derived: sum of 4 quarters · filed 2013-03-26
2011-03-31$1.77M
10-K · filed 2013-03-26
$3.90M
derived: sum of 2 quarters · filed 2013-03-26
$5.99M
derived: sum of 3 quarters · filed 2013-03-26
$8.18M
derived: sum of 4 quarters · filed 2013-03-26
2010-12-31$2.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16
$4.22M
derived: sum of 2 quarters · filed 2012-04-16
$6.41M
derived: sum of 3 quarters · filed 2012-04-16
$8.30M
10-K · filed 2012-04-16
2010-09-30$2.09M
10-Q · filed 2011-11-14
$4.27M
derived: sum of 2 quarters · filed 2011-11-14
$6.17M
10-Q · filed 2011-11-14
2010-06-30$2.19M
10-Q · filed 2011-08-05
$4.08M
10-Q · filed 2011-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02